AADAC antibody (AA 228-273) (Cy5)
Quick Overview for AADAC antibody (AA 228-273) (Cy5) (ABIN1408846)
Target
See all AADAC AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 228-273
-
Purpose
- AADAC Polyclonal Antibody, Cy5 Conjugated
-
Cross-Reactivity
- Mouse, Rat
-
Predicted Reactivity
- Human,Cow,Sheep,Pig,Horse,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human AADAC
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB(1:300-5000), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))
-
Alternative Name
- AADAC
-
Background
-
Synonyms: DAC, CES5A1, Arylacetamide deacetylase, AADAC
Background: Displays cellular triglyceride lipase activity in liver, increases the levels of intracellular fatty acids derived from the hydrolysis of newly formed triglyceride stores and plays a role in very low-density lipoprotein assembly. Displays serine esterase activity in liver. Deacetylates a variety of arylacetamide substrates, including xenobiotic compounds and procarcinogens, converting them to the primary arylamide compounds and increasing their toxicity.
-
Gene ID
- 13
-
UniProt
- P22760
Target
-